Oxidative Stress Assay Market Report by Product, Technology (ELISA, Flow Cytometry, Chromatography, Microscopy, High-Content Screening, Label-Free Detection, and Others), Test Type, End User, and Region 2024-2032
산화 스트레스 분석 시장 규모는 2023년 8억 6,530만 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 18억 2,420만 달러에 이를 전망이며, 2024년과 2032년 사이에 8.4%의 복합 연간 성장률(CAGR)을 보일 것으로 예측했습니다.
산화 스트레스는 세포와 생물 내에서 산소 유래의 자유 라디칼이 과도하게 생성되어 내재하는 항산화 방어 기능을 압도하는 건강 상태입니다. 산화 스트레스는 단백질, 지질, 핵산에 산화적 손상을 일으켜 암, 천식, 허혈, 당뇨병, 심혈관 질환, 신경퇴행성 질환의 발병으로 이어질 수 있습니다. 자유 라디칼은 건강 관리 연구자들이 메커니즘과 반응을 더 깊이 이해하기 위해 많은 분석을 사용하여 평가됩니다.
자유 라디칼은 생물학적 요인, 건강에 해로운 식생활, 대기 오염 등에 의해 생성됩니다. 이것은 흡연자와 알코올 섭취자 증가와 함께 산화 스트레스를 일으킬 위험을 높여 시장의 성장을 강화하고 있습니다. 이 외에도 산화 스트레스로 인해 다양한 병적 상태가 개척되고 노화 과정이 가속화됨에 따라 시장 성장을 뒷받침하고 있습니다. 게다가 바이오의약품산업의 성장, 연구개발(R&D) 활동에 대한 투자 증가, 창약을 위한 고콘텐트 스크리닝 등의 기술 진보도 시장 성장을 자극하는 다른 주요 요인으로 작용하고 있다 합니다. 또한, 산화 스트레스는 코로나 바이러스 감염(COVID-19)의 중증화에 기여하는 주요 요인으로 간주됩니다. 또한 산화 스트레스는 환자의 다장기 부전의 원인으로 평가됩니다. 이 질병과 산화 스트레스의 상호 관계에 대한 현재 진행중인 연구는 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 산화 스트레스 분석 시장은 지금까지 어떻게 추이하고 향후 어떻게 추이할 것인가?
- COVID-19는 세계의 산화 스트레스 분석 시장에 어떤 영향을 미치는가?
- 주요 지역 시장은?
- 제품별 시장 분석은?
- 기술별 시장 분석은?
- 검사 유형별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 산화 스트레스 분석 시장의 구조와 주요 기업은?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 산화 스트레스 분석 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
제7장 시장 분석 : 기술별
- ELISA(효소 면역 측정법)
- 플로우 사이토메트리
- 크로마토그래피
- 현미경 검사
- HCS(High Content Screening)
- 라벨 프리 검출
- 기타
제8장 시장 분석 : 검사 유형별
- 간접 분석
- 시장 동향
- 주요 유형
- 단백질 기반 분석
- 지질 기반 분석
- 핵산 기반 분석
- 시장 예측
- 항산화능 분석
- 시장 동향
- 주요 유형
- 글루타티온 분석
- 아스코르브산 검정
- 세포 기반 외인성 항산화 물질 검정
- 시장 예측
- 효소 기반 분석
- 활성산소종에 기초한 검정
제9장 시장 내역 : 최종 사용자별
제10장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제14장 가격 분석
제15장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Abcam PLC
- AMS Biotechnology(Europe) Ltd.
- Biovision Inc.(Boai NKY Medical Holdings Ltd.)
- Cell Biolabs Inc.
- Enzo Biochem Inc.
- ImmunoChemistry Technologies LLC
- Merck KGaA
- Oxford Biomedical Research
- Promega Corporation
- Qiagen NV
- Thermo Fisher Scientific Inc.
BJH
The global oxidative stress assay market size reached US$ 865.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,824.2 Million by 2032, exhibiting a growth rate (CAGR) of 8.4% during 2024-2032.
Oxidative stress is a health condition wherein excessive production of oxygen-derived free radicals within a cell or organism overwhelms the intrinsic antioxidant defenses. It causes oxidative damage to proteins, lipids and nucleic acids, which can further lead to the development of cancer, asthma, ischemia, diabetes, and cardiovascular and neurodegenerative diseases. It is assessed using a number of assays that help healthcare researchers gain a better understanding of the mechanisms and responses of the condition.
Free radicals can be produced due to biological factors, unhealthy dietary habits and air pollution. This, in confluence with the rising number of individuals who smoke and consume alcohol, is escalating the risk of developing oxidative stress, which, in turn, is strengthening the market growth. Apart from this, the development of various pathologic conditions and acceleration of the aging process on account of oxidative stress is also bolstering the market growth. Furthermore, the growing biopharmaceutical industry, increasing investments in the research and development (R&D) activities and technological advancements, such as high-content screening for drug discovery, are acting as other major factors stimulating the market growth. Moreover, oxidative stress is also being considered as a major factor contributing to the severity of the coronavirus disease (COVID-19). It is also being evaluated as a probable cause of multi-organ failure among patients. The ongoing studies on the interrelation between the disease and oxidative stress are expected to positively influence the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oxidative stress assay market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, technology, test type and end user.
Breakup by Product:
Reagents and Consumables
Instruments
Services
Breakup by Technology:
ELISA (Enzyme-Linked Immunosorbent Assay)
Flow Cytometry
Chromatography
Microscopy
High-Content Screening
Label-Free Detection
Others
Breakup by Test Type:
Indirect Assays
Protein-Based Assays
Lipid-Based Assays
Nucleic Acid-Based Assays
Antioxidant Capacity Assays
Glutathione Assays
Ascorbic Acid Assays
Cell-Based Exogenous Antioxidant Assays
Enzyme-Based Assays
Reactive Oxygen Species-Based Assays
Breakup by End User:
Pharmaceutical Industry
Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abcam PLC, AMS Biotechnology (Europe) Ltd., Biovision Inc. (Boai NKY Medical Holdings Ltd.), Cell Biolabs Inc., Enzo Biochem Inc., ImmunoChemistry Technologies LLC, Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global oxidative stress assay market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global oxidative stress assay market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global oxidative stress assay market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oxidative Stress Assay Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents and Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 ELISA (Enzyme-Linked Immunosorbent Assay)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Flow Cytometry
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Chromatography
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Microscopy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 High-Content Screening
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Label-Free Detection
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Test Type
- 8.1 Indirect Assays
- 8.1.1 Market Trends
- 8.1.2 Major Types
- 8.1.2.1 Protein-Based Assays
- 8.1.2.2 Lipid-Based Assays
- 8.1.2.3 Nucleic Acid-Based Assays
- 8.1.3 Market Forecast
- 8.2 Antioxidant Capacity Assays
- 8.2.1 Market Trends
- 8.2.2 Major Types
- 8.2.2.1 Glutathione Assays
- 8.2.2.2 Ascorbic Acid Assays
- 8.2.2.3 Cell-Based Exogenous Antioxidant Assays
- 8.2.3 Market Forecast
- 8.3 Enzyme-Based Assays
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Reactive Oxygen Species-Based Assays
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pharmaceutical Industry
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abcam PLC
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 AMS Biotechnology (Europe) Ltd.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Biovision Inc. (Boai NKY Medical Holdings Ltd.)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Cell Biolabs Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Enzo Biochem Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 ImmunoChemistry Technologies LLC
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Biomedical Research
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Promega Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Qiagen N.V.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
